HOLX Stock Recent News

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI.

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market. According to Roots Analysis, the IVD market is projected to witness a 6.2% compound annual growth rate through 2035.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report.

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Hologic (HOLX) concluded the recent trading session at $61.27, signifying a +0.67% move from its prior day's close.

HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing global uncertainties remain a drag.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #governance--Wayde McMillan Elected to Hologic Board of Directors.

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025.

Hologic (HOLX) reachead $61.77 at the closing of the latest trading day, reflecting a +0.73% change compared to its last close.